The options may be chosen on the product page Product Description AOD9604 Peptide | Buy AOD9604 UK | GH Fragment 176-191 | Research Use Only AOD9604 also known as GH Fragment 176-191 is a synthetic 16-amino acid peptide derived from the C-terminal region of human growth hormone (hGH), originally developed by Metabolic Pharmaceuticals in Australia as a selective lipolytic research compound
Bone marrow disorders: Diseases affecting the bone marrow, such as leukemia, aplastic anemia, and myelodysplastic syndromes, can interfere with platelet production
T., Maruvada, P., Hager, G
Indicated in the physical preparation of high performance horses, subjected to stress, growing, convalescent or with chronic fatigue
In the context of psoriasis, pathways linked to lipogenesis and cholesterol synthesis appear to directly impact the differentiation and functionality of Th17 cells
In the U.S., the FDA has not approved it for medical use and classifies it as a research chemical for scientific studies